Nicholas Grund
2016
In 2016, Nicholas Grund earned a total compensation of $2.3M as Chief Commercial Officer at AMAG Pharmaceuticals.
Compensation breakdown
| Bonus | $100,000 |
|---|---|
| Non-Equity Incentive Plan | $231,750 |
| Option Awards | $567,824 |
| Salary | $432,692 |
| Stock Awards | $914,560 |
| Other | $7,950 |
| Total | $2,254,776 |
Grund received $914.6K in stock awards, accounting for 41% of the total pay in 2016.
Grund also received $100K in bonus, $231.8K in non-equity incentive plan, $567.8K in option awards, $432.7K in salary and $8K in other compensation.
Rankings
In 2016, Nicholas Grund's compensation ranked 4,357th out of 14,075 executives tracked by ExecPay. In other words, Grund earned more than 69.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,357 out of 14,075 | 69th |
Division Manufacturing | 1,531 out of 5,489 | 72nd |
Major group Chemicals And Allied Products | 461 out of 1,895 | 76th |
Industry group Drugs | 334 out of 1,538 | 78th |
Industry Pharmaceutical Preparations | 262 out of 1,176 | 78th |
Source: SEC filing on April 20, 2017.
Grund's colleagues
We found five more compensation records of executives who worked with Nicholas Grund at AMAG Pharmaceuticals in 2016.
2016
William Heiden
AMAG Pharmaceuticals
Chief Executive Officer
2016
Frank Thomas
AMAG Pharmaceuticals
Chief Operating Officer
2016
Edward Myles
AMAG Pharmaceuticals
Chief Financial Officer
2016
Julie Krop
AMAG Pharmaceuticals
Chief Medical Officer
2016
Joseph Vittiglio
AMAG Pharmaceuticals